Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1994-2-10
|
| pubmed:abstractText |
HLA expression is frequently altered in tumours compared to the tissue from which they originate. Given the central role of MHC products in the restriction of T-cell recognition, regulation of tumour HLA expression might be a strategy for the evasion of immune surveillance by the malignant cells. Federico Garrido, Peter Stern and colleagues present data from a variety of tumour types, suggesting that HLA class I alterations may occur at a particular step between the development of an in situ lesion and an invasive carcinoma.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0167-5699
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
491-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8274189-Carcinoma in Situ,
pubmed-meshheading:8274189-Female,
pubmed-meshheading:8274189-Gene Expression,
pubmed-meshheading:8274189-HLA Antigens,
pubmed-meshheading:8274189-Humans,
pubmed-meshheading:8274189-Models, Biological,
pubmed-meshheading:8274189-Neoplasm Invasiveness,
pubmed-meshheading:8274189-Neoplasms,
pubmed-meshheading:8274189-Precancerous Conditions
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Natural history of HLA expression during tumour development.
|
| pubmed:affiliation |
Dept of Analisis Clínicos e Immunología, Hospital Virgen de las Nieves, Universidad de Granada, Spain.
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|